Stratrix
Company data sheet · Becton Dickinson

Becton Dickinson: leaders came and went.

Industry
Surgical & Medical Instruments & Apparatus
Headquarters
United States
Ticker
BDX (NYSE)
Sources
SEC filings (1994–2026), Stratrix's verified Decision Cases, market data and official economic statistics for the United States
Data as of
November 8, 2026
  1. Leaders came and went. Becton Dickinson filed 35 leadership changes since 2016, more than 86% of large manufacturers (the median is 20). The day after each, its shares moved a median 0.1 points against its sector. The news was rarely news.
  2. Profitable every year. Becton Dickinson made money in each of its last ten fiscal years, from $0.3 billion (fiscal 2018) to $2.1 billion (fiscal 2021).

Financial results

Fiscal yearRevenueNet income
2016$12.5 billion$1 billion
2017$12.1 billion$1.1 billion
2018$16 billion$0.3 billion
2019$17.3 billion$1.2 billion
2020$16.1 billion$0.9 billion
2021$19.1 billion$2.1 billion
2022$18.9 billion$1.8 billion
2023$19.4 billion$1.5 billion
2024$20.2 billion$1.7 billion
2025$21.8 billion$1.7 billion

As reported in its annual filings. Losses in red.

Has Becton Dickinson had layoffs?

Job cuts, severance and restructuring

None of Becton Dickinson’s annual reports for 2023 to 2025 describes a layoff, workforce reduction or restructuring.

Reported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedRestructuring chargesCash paid for restructuring
2016-09-30$526 million$148 million
2017-09-30$85 million$57 million
2020-09-30$84 million$80 million
2021-09-30$44 million$56 million
2022-09-30$123 million$82 million
2023-09-30$239 million$165 million
2024-09-30$387 million$305 million
2025-09-30$275 million$231 million

Becton Dickinson has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.

What has Becton Dickinson acquired?

Deals its annual reports describe

BusinessDealWhenValue
Parata Systems
“On July 18, 2022, BD completed the acquisition of Parata Systems (“Parata”), an innovative provider of pharmacy automation solutions, for total cash consideration of $1.548 billion.” 10-K for 2023
acquisitionOn July 18, 2022—
Surgical Instrumentation platform
“In August 2023, BD completed the sale of the Interventional segment’s Surgical Instrumentation platform pursuant to a definitive agreement that was signed in June 2023.” 10-K for 2023
divestitureIn August 2023—
Edwards Lifesciences’ Critical Care product group (renamed BD Advanced Patient Monitoring)
“On September 3, 2024, BD completed the acquisition of Critical Care, which was renamed as BD Advanced Patient Monitoring.” 10-K for 2024
acquisitionSeptember 3, 2024—
Edwards Lifesciences’ Critical Care product group
“On September 3, 2024, BD completed the acquisition of Edwards Lifesciences’ Critical Care product group, which was renamed as BD Advanced Patient Monitoring.” 10-K for 2025
acquisitionOn September 3, 2024—
Biosciences and Diagnostic Solutions business (combination with Waters Corporation)
“On July 13, 2025, BD entered into a definitive agreement to combine its Biosciences and Diagnostic Solutions business with Waters Corporation (“Waters”) in a Reverse Morris Trust (“RMT”) transaction.” 10-K for 2025
agreed divestitureOn July 13, 2025—
Interventional segment's Surgical Instrumentation platform
“BD recognized a pre-tax gain on the sale of approximately $268 million, which was recorded as a component of Other operating expense (income), net in fiscal year 2023.” 10-K for 2025
divestiture—approximately $268 million
Reported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Cash received from selling businessesGoodwill from acquisitions
2016-09-30$0$158 million—
2017-09-30$174 million$165 million$143 million
2018-09-30$15.15 billion$534 million$15.22 billion
2019-09-30$0$477 million—
2020-09-30$164 million$0$117 million
2021-09-30$508 million$0$264 million
2022-09-30$2.07 billion$0$1.07 billion
2023-09-30$0$540 million—
2024-09-30$3.92 billion$0$1.83 billion
2025-09-30$0$0$4 million

Deal filings since 2016

Who are Becton Dickinson's competitors?

Who Becton Dickinson names

Becton Dickinson’s annual reports for 2023 to 2025 describe its competition by kind of business and do not name competing companies.

Who names Becton Dickinson

Companies whose own annual reports name Becton Dickinson as a competitor.

  1. Alere · 2016

    “Some competitors in the market for professional rapid diagnostic products, such as Becton Dickinson, are large companies with substantial resources, while numerous smaller, yet aggressive companies also compete with us, particularly where barriers to entry are low.” 10-K for 2016
  2. Bio-rad Laboratories · 2025

    “Major competitors in this market include Becton Dickinson, Danaher, Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific.” 10-K for 2025
  3. Hologic · 2025

    “In our Diagnostics business, our primary competitors include Roche Diagnostics, Abbott Laboratories and Cepheid in the molecular diagnostics field, and Becton Dickinson in the cytology field, as well as a wide range of diagnostics companies that sell a single or limited number of assays or products in only a specific market segment (i.e., Cytology, Acute Care, or Oncology Services).” 10-K for 2025
  4. ICU Medical names it as “Becton Dickinson ("BD")” · 2025

    “We compete with products and systems marketed by Becton Dickinson ("BD"), Baxter International ("Baxter"), B. Braun Medical, Inc.” 10-K for 2025
  5. Solventum · 2025

    “Our principal competitors in this segment include Becton Dickinson, Hartmann, ICU Medical, Medline, Cardinal Health, Fortive, Steris, MDF Instruments, and BSN.” 10-K for 2025

What are Becton Dickinson's subsidiaries?

Subsidiaries it lists

SubsidiaryJurisdiction
Accuri Cytometers, Inc.Delaware
Adaptec Medical Devices LLCDelaware
Alverix, Inc.Delaware
Augusta Life Sciences Corp.Delaware
Augusta Life Sciences US Holdco I LLCDelaware
Augusta Life Sciences US Holdco II LLCDelaware
Augusta Life Sciences US Opco I LLCDelaware
Augusta Life Sciences US Opco II LLCDelaware
Augusta Life Sciences US Spinco LLCDelaware
Bard Access Systems, Inc.Utah
Bard Acquisition Sub, Inc.Delaware
Bard ASDI, Inc.New Jersey
Bard Brachytherapy, Inc.Delaware
Bard Devices, Inc.Delaware
Bard IP Holdings Inc.Delaware
Bard Healthcare, Inc.Texas
Bard International, Inc.Delaware
Bard MRL Acquisition Corp.Delaware
Bard Peripheral Vascular, Inc.Arizona
BD Nebula US Formco I LLCDelaware
BD Nebula US Formco II LLCDelaware
BD Ventures LLCNew Jersey
BDX INO LLCDelaware
Becton Dickinson Biosciences, Systems and Reagents Inc.California
Becton Dickinson Global Holdings I Inc.Delaware
Becton Dickinson Global Holdings IV LLCDelaware
Becton Dickinson Global Holdings VI LLCDelaware
Becton Dickinson Global Holdings VII LLCDelaware
Becton Dickinson Global Holdings VIII LLCDelaware
Becton Dickinson Infusion Therapy Systems Inc.Delaware
Becton Dickinson Korea Holding, Inc.Delaware
Becton Dickinson Malaysia, Inc.Oregon
Becton Dickinson Matrex Holdings, Inc.Delaware
Becton Dickinson Overseas Services Ltd.Nevada
Becton Dickinson Venture LLCDelaware
Bridger Biomed, Inc.Montana
C. R. Bard, Inc.New Jersey
Cardal II, LLCDelaware
CareFusion 213, LLCDelaware
CareFusion 2200, Inc.Delaware
CareFusion 2201, Inc.Delaware
CareFusion 302, LLCDelaware
CareFusion 303, Inc.Delaware
CareFusion CorporationDelaware
CareFusion Manufacturing, LLCDelaware
CareFusion Resources, LLCDelaware
CareFusion Solutions, LLCDelaware
CAS Medical Systems, Inc.Delaware
Cell Analysis Systems, IncIllinois
Cellular Research, Inc.Delaware
Chudy Group, LLCDelaware
CRISI Medical Systems, Inc.Delaware
Davol Inc.Delaware
DVL Acquisition Sub, Inc.Delaware
Dymax CorporationPennsylvania
Echo-US LLCDelaware
Enturican, Inc.Kansas
FJ International, Inc.Oregon
FlowCardia, Inc.Delaware
FlowCardia, LLCDelaware
FlowJo LLCOregon
Franklin Lakes Enterprises, L.L.C.New Jersey
Galatea Surgical, Inc.Delaware
Gesco International, Inc.Massachusetts
Gesco International, LLCMassachusetts
GSL Solutions, Inc.Washington
GSL Holdings, Inc.Washington
HandyLab, Inc.Delaware
IBD Holdings LLCDelaware
Iontophoretics CorporationUtah
JoHome LLCOregon
Liberator Health and Education Services, Inc.Florida
Liberator Health and Wellness, Inc.Florida
Liberator Medical Holdings, Inc.Nevada
Liberator Medical Supply, Inc.Florida
Loma Vista Medical, Inc.Delaware
Loma Vista Medical, LLCDelaware
Lutonix, Inc.Delaware
Medafor, Inc.Minnesota
MedChem Products, Inc.Massachusetts
Medegen, LLCCalifornia
Med-Design CorporationDelaware
Med Design Investment Holdings, Inc.Delaware
Medinservice.com, Inc.Utah
Medivance, Inc.Delaware
Med-Safe Systems, Inc.California
NAT Diagnostics Inc.Delaware
Navarre Biomedical, LLCMinnesota
Navarre Biomedical, Ltd.Minnesota
Neomend, Inc.Delaware
Nirvana Sciences, Inc.Delaware
NOW Medical Distribution, Inc.Delaware
NOW Medical Distribution, LLCDelaware
Omega Biosystems IncorporatedDelaware
Parata Systems, LLCDelaware
Pembroke Blocker LLCDelaware
Pembroke Foreign Blocker LLCDelaware
Pembroke Parent LLCDelaware
PharMingenCalifornia
ProSeed, Inc.New Jersey
PureWick CorporationCalifornia
Roberts Laboratories, Inc.Arizona
Rochester Medical CorporationMinnesota
Safety Syringes CorporationUtah
Safety Syringes, Inc.California
Scanwell Health, Inc.Delaware
SenoRx, Inc.Delaware
SenoRx, LLCDelaware
Shield Healthcare Centers, Inc.Delaware
Sirigen, Inc.California
Specialized Cooperative CorporationUtah
Specialized Health Products International, Inc.Delaware
Specialized Health Products International, LLCDelaware
Specialized Health Products, Inc.Utah
Surgical Site Solutions, Inc.Wisconsin
Synergy Medical USA Inc.Delaware
Targa Buyer, LLCDelaware
Targa International Holdco, Inc.Delaware
Targa Parent Holdings, LLCDelaware
Tepha, Inc.Delaware
Tri-County Medical & Ostomy Supplies, Inc.Tennessee
TriPath Imaging, Inc.Delaware
TVA Medical, Inc.Delaware
Vascular Pathways, Inc.Delaware
Velano Vascular, Inc.Delaware
Venclose, Inc.Delaware
Venetec International, Inc.Delaware
Venetec International, LLCDelaware
Y-Med, Inc.Delaware
Y-Med, LLCDelaware
ZebraSci, Inc.Delaware
Angiomed GmbH & Co. Medizintechnik KGGermany
Augusta Life Sciences Australia Pty LtdAustralia
Augusta Life Sciences Austria GmbHAustria
Augusta Life Sciences B.V.Netherlands
Augusta Life Sciences CanSpin HoldCo ULCCanada
Augusta Life Sciences Colombia S.A.S.Colombia
Augusta Life Sciences Denmark ASDenmark
Augusta Life Sciences France S.A.S.France
Augusta Life Sciences Hong Kong LimitedHong Kong
Augusta Life Sciences Israel Ltd.Israel
Augusta Life Sciences Italy S.r.l.Italy
Augusta Life Sciences Japan G.K.Japan
Augusta Life Sciences New Zealand ULCNew Zealand
Augusta Life Sciences Singapore Pte Ltd.Singapore
Augusta Life Sciences Spinco Canada ULCCanada
Augusta Life Sciences Sweden ABSweden
Augusta LIfe Sciences UK Ltd.United Kingdom
Bard (Thailand) LimitedThailand
Bard Australia Pty. LimitedAustralia

The list is long; these are the first 150 as the company lists them. From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.

Layoffs, acquisitions, competitors and subsidiaries are read from Becton Dickinson’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023), as of 2025-11-25.

The full data sheet · Data Plan

Everything behind these findings, ready for your board deck.

  • Market reaction to disclosed decisions: 59 decision filings since 2016, each linked to the SEC, with the share return against its sector and the US market the next day and the next year (36 with market data).
  • Economic context: 7 measures for the United States, every year since 2016, from the official sources.
  • Peer comparison: against 264 companies of its size in its sector.
  • Financial results: ten years of revenue, operating and net income, and every annual report, linked.
  • Methods and sources, so each number can be checked and cited.

The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.

Tools to try

More from Stratrix

The Business Model Wizard

Make the seven choices that define your model, test your numbers against real companies, and meet the rival AI would build against you.

Free · about twelve minutesBuild your Model Thesis →

Stratrix Team

Every Casebook, three Strategy Packs a seat each year and Ask Stratrix, for teams that face these decisions all year.

$1,999 a year · $499 a seatWhat is included →

New analyses, by email

The defining moves in business, and what they teach, as they publish.

We'll email you a link to confirm. Unsubscribe anytime. Privacy policy.